Wren
Download Wren on the App Store

GLP-1 side effects: how common they are and how to track them

Updated · Wren editorial team · sources: FDA prescribing information and peer-reviewed studies

Stomach and gut side effects are the most common. In the Wegovy 2.4 mg trials, 44% of people had nausea (vs 16% on placebo), 30% diarrhea, 24% vomiting and 24% constipation. On Zepbound, 25–29% had nausea depending on dose (vs 8% on placebo), 19–23% diarrhea, 8–13% vomiting and 11–17% constipation. In both trials these were mostly mild to moderate and happened mainly while the dose was being increased.

How common are GLP-1 side effects?

Most common side effects in the weight-management trials summarized in each label (medicine vs placebo)
Side effectWegovy 2.4 mgZepbound 5 / 10 / 15 mgPlacebo (Wegovy / Zepbound trials)
Nausea44%25% / 29% / 28%16% / 8%
Diarrhea30%19% / 21% / 23%16% / 8%
Vomiting24%8% / 11% / 13%6% / 2%
Constipation24%17% / 14% / 11%11% / 5%

Wegovy figures pool three placebo-controlled trials (2,116 people on Wegovy); Zepbound figures pool SURMOUNT-1 and a second trial. The two drugs were not compared head to head, so the columns aren't a ranking.

What to log, and why it helps

Patterns are easier to see than to remember. Women often notice that bloating, constipation or cravings shift across the month — see GLP-1s and your menstrual cycle.

When to get medical help

Contact your prescriber or seek care right away for severe or ongoing stomach pain, vomiting you can't stop, signs of dehydration (very little urine, dizziness), or any symptom that worries you. The medication guide that came with your prescription lists the serious warnings for your medicine.

Bring a real log to your next appointment

Wren records side effects next to your dose days and cycle, and exports a doctor-ready PDF and CSV.

Download Wren on the App Store

Frequently asked questions

What is the most common side effect of Ozempic, Wegovy, Mounjaro and Zepbound?

Nausea. In the trials summarized in the labels, it affected 44% of people on Wegovy 2.4 mg and 25–29% of people on Zepbound, compared with 8–16% on placebo.

When do GLP-1 side effects usually happen?

The SURMOUNT-1 tirzepatide trial reported gastrointestinal events mostly during dose escalation, and STEP 1 described semaglutide's nausea and diarrhea as typically transient and mild to moderate.

Do GLP-1 side effects go away?

For many people they ease after the first weeks on a stable dose. If they don't, or they are severe, tell your prescriber. Severe or persistent stomach pain, vomiting that won't stop, or signs of dehydration need prompt medical care.

Why should I log my side effects?

A dated log shows your doctor which dose and which days the symptoms follow, which makes dose decisions easier than recalling it from memory.

Sources

  1. WEGOVY (semaglutide) prescribing information — Novo Nordisk via DailyMed (NIH), label effective June 18, 2026
  2. ZEPBOUND (tirzepatide) prescribing information — Eli Lilly via DailyMed (NIH), label effective August 28, 2026
  3. Once-weekly semaglutide in adults with overweight or obesity (STEP 1) — Wilding et al., New England Journal of Medicine, 2021
  4. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — Jastreboff et al., New England Journal of Medicine, 2022